|
EHF expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.83424411612532E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.30639999987403E-07 |
| Normal-vs-Stage2 |
8.261800E-01 |
| Normal-vs-Stage3 |
2.0210000000187E-06 |
| Normal-vs-Stage4 |
2.571400E-04 |
| Stage1-vs-Stage2 |
1.150500E-02 |
| Stage1-vs-Stage3 |
5.657700E-02 |
| Stage1-vs-Stage4 |
4.063600E-02 |
| Stage2-vs-Stage3 |
5.024200E-04 |
| Stage2-vs-Stage4 |
1.240800E-03 |
| Stage3-vs-Stage4 |
4.527200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.86635168325711E-12 |
| Normal-vs-AfricanAmerican |
1.935830E-02 |
| Normal-vs-Asian |
9.643900E-03 |
| Caucasian-vs-AfricanAmerican |
5.977400E-01 |
| Caucasian-vs-Asian |
9.221200E-01 |
| AfricanAmerican-vs-Asian |
6.430000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.436000E-04 |
| Normal-vs-Female |
4.1091019475914E-11 |
| Male-vs-Female |
1.836640E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.58580000026087E-07 |
| Normal-vs-Age(41-60Yrs) |
2.36639999995347E-06 |
| Normal-vs-Age(61-80Yrs) |
2.722100E-03 |
| Normal-vs-Age(81-100Yrs) |
1.853450E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.391800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.155800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.717800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.497200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.510800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.206000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.899000E-03 |
| Classical-VS-Follicular |
1.6242562850266E-12 |
| Classical-VS-Other |
8.048100E-02 |
| Classical-VS-Normal |
1.64568358940187E-12 |
| Tall-VS-Follicular |
2.86620000000681E-06 |
| Tall-VS-Other |
4.239600E-03 |
| Tall-VS-Normal |
7.64460000000078E-05 |
| Follicular-VS-Other |
9.891700E-02 |
| Follicular-VS-Normal |
1.64086999999702E-05 |
| Other-VS-Normal |
4.475000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.501600E-03 |
| Normal-vs-N1 |
7.86130000000052E-05 |
| N0-vs-N1 |
1.502740E-03 |
|
|
